Position in RLYB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,389,552
+$3,686,160 QoQ
Shares Held
524,347
0.0% QoQ
Ownership
9.87%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#4
of 37 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLYB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VIKING GLOBAL INVESTORS LP holds $2,489,856,848 across 17 Biotechnology names. RLYB ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
9,949,219 | $741,017,831 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
7,616,563 | $435,819,734 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
6,271,467 | $221,947,217 | |
| 4 | MANE |
Veradermics, Inc
|
1,561,494 | $191,970,072 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
1,503,478 | $143,086,001 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
4,203,567 | $142,458,885 | |
| 7 | SION |
Sionna Therapeutics, Inc.
|
3,195,181 | $140,556,012 | |
| 8 | PHVS |
Pharvaris N.V.
|
3,653,310 | $126,331,459 |
All Filings in RLYB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,389,552 | 524,347 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,703,392 | 524,347 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,877,617 | 4,194,777 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,093,193 | 4,194,777 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,417,834 | 4,194,777 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,747,578 | 4,194,777 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,026,985 | 4,194,777 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,907,889 | 4,194,777 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,621,001 | 4,194,777 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,760,337 | 4,194,777 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,025,517 | 4,194,777 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,136,398 | 4,194,777 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $23,742,437 | 4,194,777 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $23,952,176 | 4,194,777 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $27,559,684 | 4,194,777 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $60,698,423 | 4,194,777 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $31,670,566 | 4,194,777 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $29,279,543 | 4,194,777 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $40,018,172 | 4,194,777 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $73,744,179 | 4,194,777 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||